In this study, we focused on investigating the expression patterns of Lactylation-related genes and constructed a LRGs signature based on four genes—KIF2C, CALD1, HSPE1, and IFI16—that were highly expressed in glioma tissues, which effectively stratified patient risk and assisted clinicians in developing personalized treatment strategies. This evidence concerns the gene IFI16 and glioma.